On July 29th 2016, the new process in England for cancer drugs seeking license went live - changing both the shape and potential requirements of the submissions process.
One of the biggest challenges that global life science organisations have to overcome is managing the creation, re-purposing, promotion, and distribution of content as a plethora of new and more dy
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
